239 related articles for article (PubMed ID: 16353950)
1. Recognition of psychostimulants, antidepressants, and other inhibitors of synaptic neurotransmitter uptake by the plasma membrane monoamine transporters.
Surratt CK; Ukairo OT; Ramanujapuram S
AAPS J; 2005 Oct; 7(3):E739-51. PubMed ID: 16353950
[TBL] [Abstract][Full Text] [Related]
2. Regulation of monoamine transporters: influence of psychostimulants and therapeutic antidepressants.
Jayanthi LD; Ramamoorthy S
AAPS J; 2005 Oct; 7(3):E728-38. PubMed ID: 16353949
[TBL] [Abstract][Full Text] [Related]
3. Structural domains of catecholamine transporter chimeras involved in selective inhibition by antidepressants and psychomotor stimulants.
Buck KJ; Amara SG
Mol Pharmacol; 1995 Dec; 48(6):1030-7. PubMed ID: 8848002
[TBL] [Abstract][Full Text] [Related]
4. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
5. [Function of monoamine neurotransmitter transporters].
Sasa M
Nihon Rinsho; 2001 Aug; 59(8):1457-64. PubMed ID: 11519142
[TBL] [Abstract][Full Text] [Related]
6. Neurotransmitter and psychostimulant recognition by the dopamine transporter.
Wang KH; Penmatsa A; Gouaux E
Nature; 2015 May; 521(7552):322-7. PubMed ID: 25970245
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
8. Monoamine transporters and psychostimulant drugs.
Rothman RB; Baumann MH
Eur J Pharmacol; 2003 Oct; 479(1-3):23-40. PubMed ID: 14612135
[TBL] [Abstract][Full Text] [Related]
9. Identification of a single amino acid, phenylalanine 586, that is responsible for high affinity interactions of tricyclic antidepressants with the human serotonin transporter.
Barker EL; Blakely RD
Mol Pharmacol; 1996 Oct; 50(4):957-65. PubMed ID: 8863842
[TBL] [Abstract][Full Text] [Related]
10. Psychostimulants and monoamine transporters: upsetting the balance.
Elliott JM; Beveridge TJ
Curr Opin Pharmacol; 2005 Feb; 5(1):94-100. PubMed ID: 15661632
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of a novel monoamine transporter in the human brain.
Engel K; Zhou M; Wang J
J Biol Chem; 2004 Nov; 279(48):50042-9. PubMed ID: 15448143
[TBL] [Abstract][Full Text] [Related]
12. Monoamine transporter inhibitors and substrates as treatments for stimulant abuse.
Howell LL; Negus SS
Adv Pharmacol; 2014; 69():129-76. PubMed ID: 24484977
[TBL] [Abstract][Full Text] [Related]
13. Probing dopamine transporter structure and function by Zn2+-site engineering.
Loland CJ; Norgaard-Nielsen K; Gether U
Eur J Pharmacol; 2003 Oct; 479(1-3):187-97. PubMed ID: 14612149
[TBL] [Abstract][Full Text] [Related]
14. Neurotransmitter transporters and their impact on the development of psychopharmacology.
Iversen L
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S82-8. PubMed ID: 16402124
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluation.
Kulkarni SS; Grundt P; Kopajtic T; Katz JL; Newman AH
J Med Chem; 2004 Jun; 47(13):3388-98. PubMed ID: 15189035
[TBL] [Abstract][Full Text] [Related]
16. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
Ribeiro P; Patocka N
Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
[TBL] [Abstract][Full Text] [Related]
17. Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.
Haenisch B; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jan; 381(1):33-9. PubMed ID: 20012264
[TBL] [Abstract][Full Text] [Related]
18. Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6.
Chen NH; Reith ME; Quick MW
Pflugers Arch; 2004 Feb; 447(5):519-31. PubMed ID: 12719981
[TBL] [Abstract][Full Text] [Related]
19. Emerging structure-function relationships defining monoamine NSS transporter substrate and ligand affinity.
Wang CI; Lewis RJ
Biochem Pharmacol; 2010 Apr; 79(8):1083-91. PubMed ID: 19954741
[TBL] [Abstract][Full Text] [Related]
20. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
